ArticleFrontiers in oncology2021

A Short-Term Efficacy of Anlotinib in the Treatment of Refractory Nasopharyngeal Inverted Papilloma: A Case Report.

Pan Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.